Are you Dr. Jedlicka?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 21 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
13123 E 16th Ave
Aurora, CO 80045Phone+1 720-777-1234Fax+1 303-493-7202
Summary
- Dr. Pavel Jedlicka, MD is a board certified pathologist in Aurora, Colorado. He is currently licensed to practice medicine in Colorado. He is affiliated with University of Colorado Hospital and Children's Hospital Colorado.
Education & Training
- University of ColoradoFellowship, Pediatric Pathology, 2002 - 2004
- Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 2000 - 2002
- Massachusetts General HospitalInternship, Transitional Year, 1999 - 2000
- McGill University Faculty of MedicineClass of 1999
Certifications & Licensure
- CO State Medical License 2002 - 2025
- American Board of Pathology Anatomic Pathology
- American Board of Pathology Pediatric Pathology
Publications & Presentations
PubMed
- S1P Lyase Inhibition Increased Intestinal S1P, Disrupted the Intestinal Barrier and Aggravated DSS-Induced Colitis.Prabhdeep Kaur, Thangaraj Karuppuchamy, Amruth Chilukuri, Margaret Kim, Josef Urrete
Inflammatory Bowel Diseases. 2025-02-17 - A Similar Mutation in the AAUU-Rich Elements of the Mouse TNF Gene Results in a Distinct Ileocolitic Phenotype: A New Strain of TNF-Overexpressing Mice.Amruth Chilukuri, Margaret Kim, Taniya Mitra, John M Gubatan, Josef Urrete
Inflammatory Bowel Diseases. 2025-01-04 - Dependence of PAX3-FOXO1 chromatin occupancy on ETS1 at important disease-promoting genes exposes new targetable vulnerability in Fusion-Positive Rhabdomyosarcoma.Joseph Hsieh, Etienne P Danis, Charles R Owens, Janet K Parrish, Nathan L Nowling
Oncogene. 2025-01-01